{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:18:47Z","timestamp":1791213527965,"version":"4.1.0"},"reference-count":41,"publisher":"BMJ","issue":"10","license":[{"start":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T00:00:00Z","timestamp":1759622400000},"content-version":"unspecified","delay-in-days":4,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"The training program of \u201cDouble Hundred\u201d young and middle-aged medical and health talents in Wuxi","award":["BJ020034"],"award-info":[{"award-number":["BJ020034"]}]},{"name":"Medical research project of Jiangsu Provincial Health Commission","award":["M2024017"],"award-info":[{"award-number":["M2024017"]}]},{"DOI":"10.13039\/501100008109","name":"Wuxi Science and Technology Bureau","doi-asserted-by":"crossref","award":["Y20222002"],"award-info":[{"award-number":["Y20222002"]}],"id":[{"id":"10.13039\/501100008109","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81871260"],"award-info":[{"award-number":["81871260"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"First Affiliated Hospital of Nanjing Medical University","award":["PY2022007"],"award-info":[{"award-number":["PY2022007"]}]},{"name":"Practice Innovation Program of Jiangsu Province","award":["SJCX22_0645"],"award-info":[{"award-number":["SJCX22_0645"]}]},{"name":"Practice Innovation Program of Jiangsu Province","award":["SJCX23_0688"],"award-info":[{"award-number":["SJCX23_0688"]}]},{"name":"Practice Innovation Program of Jiangsu Province","award":["SJCX24_0730"],"award-info":[{"award-number":["SJCX24_0730"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Immunother Cancer"],"accepted":{"date-parts":[[2025,9,15]]},"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The hypoxic microenvironment plays a crucial role in regulating the progression of hepatocellular carcinoma (HCC) and facilitating immune evasion. It is essential to gain a more comprehensive understanding of the pathways through which hypoxia influences HCC progression and immune evasion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We employed RNA sequencing, The Cancer Genome Atlas (TCGA) data analysis, clinical data analysis of HCC, and tissue microarray immunohistochemical analysis to identify key genes associated with hypoxia regulation and immune evasion. We investigated the biological functions of REST corepressor 2 (RCOR2) in tumor progression and immune evasion through mass cytometry, multiplex immunofluorescence, an orthotopic liver transplantation tumor model, in vitro co-culture systems, flow cytometry, and immunohistochemical analysis. Additionally, we used molecular techniques such as RNA sequencing, chromatin immunoprecipitation sequencing, and mass spectrometry to gain deeper insights into the potential molecular mechanisms underlying RCOR2.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We found that the hypoxia-related factor RCOR2 is upregulated in HCC and is associated with a poor prognosis. RCOR2 enhances the glycolytic process in HCC cells, thereby promoting the proliferation and metastasis of HCC cells under hypoxic conditions. Additionally, RCOR2 facilitates the M2 polarization of macrophages and contributes to the exhaustion of CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cells. Mechanistically, the hypoxic microenvironment increases the expression of RCOR2 through hypoxia-inducible factor 1-alpha. Concurrently, this microenvironment inhibits the ubiquitin-mediated degradation of RCOR2 by promoting its sumoylation, which facilitates its translocation to the nucleus. The sumoylation of RCOR2 further enhances the transcriptional activity of leukemia inhibitory factor (LIF). LIF, derived from HCC, contributes to the M2 polarization of macrophages, thereby facilitating immune evasion and playing a role in resistance to programmed cell death protein 1 (PD-1) therapies.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our research reveals that the RCOR2\/LIF axis within the hypoxic microenvironment of HCC plays a significant role in immune evasion and identifies novel biomarkers associated with tumor resistance to anti-PD-1 therapy. This study provides potential therapeutic targets for HCC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jitc-2025-012314","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:30:40Z","timestamp":1759732240000},"page":"e012314","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":11,"title":["Hypoxia-induced RCOR2 promotes macrophage M2 polarization and CD8\n                    <sup>+<\/sup>\n                    T-cell exhaustion by enhancing LIF transcription in hepatocellular carcinoma"],"prefix":"10.1136","volume":"13","author":[{"given":"Wenbo","family":"Jia","sequence":"first","affiliation":[{"name":"Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China"},{"name":"Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences; National Health Commission (NHC) Key Laboratory of Hepatobiliary cancers, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyi","family":"Wang","sequence":"additional","affiliation":[{"name":"Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China"},{"name":"Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences; National Health Commission (NHC) Key Laboratory of Hepatobiliary cancers, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiming","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, The Affiliated Wuxi No.2 People's Hospital of Nanjing Medical University, Wuxi, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijie","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, The Affiliated Wuxi No.2 People's Hospital of Nanjing Medical University, Wuxi, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Litao","family":"Liang","sequence":"additional","affiliation":[{"name":"Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China"},{"name":"Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences; National Health Commission (NHC) Key Laboratory of Hepatobiliary cancers, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Xu","sequence":"additional","affiliation":[{"name":"Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China"},{"name":"Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences; National Health Commission (NHC) Key Laboratory of Hepatobiliary cancers, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanzhi","family":"Feng","sequence":"additional","affiliation":[{"name":"Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China"},{"name":"Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences; National Health Commission (NHC) Key Laboratory of Hepatobiliary cancers, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingpeng","family":"Lv","sequence":"additional","affiliation":[{"name":"Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China"},{"name":"Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences; National Health Commission (NHC) Key Laboratory of Hepatobiliary cancers, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deming","family":"Zhu","sequence":"additional","affiliation":[{"name":"Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China"},{"name":"Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences; National Health Commission (NHC) Key Laboratory of Hepatobiliary cancers, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhu","family":"Zhao","sequence":"additional","affiliation":[{"name":"Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China"},{"name":"Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences; National Health Commission (NHC) Key Laboratory of Hepatobiliary cancers, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Ling","sequence":"additional","affiliation":[{"name":"Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China"},{"name":"Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences; National Health Commission (NHC) Key Laboratory of Hepatobiliary cancers, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, The Affiliated Wuxi No.2 People's Hospital of Nanjing Medical University, Wuxi, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Ai","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Pancreatic Spleen Surgery, Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongping","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, The Affiliated Wuxi No.2 People's Hospital of Nanjing Medical University, Wuxi, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianbao","family":"Kong","sequence":"additional","affiliation":[{"name":"Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China"},{"name":"Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences; National Health Commission (NHC) Key Laboratory of Hepatobiliary cancers, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3734-7112","authenticated-orcid":false,"given":"Wenzhou","family":"Ding","sequence":"additional","affiliation":[{"name":"Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China"},{"name":"Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences; National Health Commission (NHC) Key Laboratory of Hepatobiliary cancers, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,10,5]]},"reference":[{"key":"2025111301350915000_13.10.e012314.1","doi-asserted-by":"publisher","DOI":"10.3322\/CAAC.21834"},{"key":"2025111301350915000_13.10.e012314.2","doi-asserted-by":"crossref","unstructured":"Llovet JM , Zucman-Rossi J , Pikarsky E , et al . Hepatocellular carcinoma. Nat Rev Dis Primers 2016;2. doi:10.1038\/nrdp.2016.18","DOI":"10.1038\/nrdp.2016.18"},{"key":"2025111301350915000_13.10.e012314.3","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-018-0869-y","article-title":"Role of hypoxia-induced exosomes in tumor biology","volume":"17","author":"Shao","year":"2018","journal-title":"Mol Cancer"},{"key":"2025111301350915000_13.10.e012314.4","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-023-01332-8","article-title":"Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"2025111301350915000_13.10.e012314.5","first-page":"1830","article-title":"Hypoxia inducible factor (HIF-1a and HIF-2a) expression in early esophageal cancer and response to photodynamic therapy and radiotherapy","volume":"61","author":"Koukourakis","year":"2001","journal-title":"Cancer Res"},{"key":"2025111301350915000_13.10.e012314.6","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2009.219"},{"key":"2025111301350915000_13.10.e012314.7","doi-asserted-by":"publisher","DOI":"10.1038\/nrc704"},{"key":"2025111301350915000_13.10.e012314.8","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-13-0992"},{"key":"2025111301350915000_13.10.e012314.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.08.016"},{"key":"2025111301350915000_13.10.e012314.10","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-020-0273-y"},{"key":"2025111301350915000_13.10.e012314.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.04.007"},{"key":"2025111301350915000_13.10.e012314.12","doi-asserted-by":"publisher","DOI":"10.1084\/jem.189.9.1363"},{"key":"2025111301350915000_13.10.e012314.13","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-09-2587"},{"key":"2025111301350915000_13.10.e012314.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2020.05.034"},{"key":"2025111301350915000_13.10.e012314.15","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10481"},{"key":"2025111301350915000_13.10.e012314.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2013.01.006"},{"key":"2025111301350915000_13.10.e012314.17","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1038\/leu.2017.232","article-title":"B7-H4 enhances the differentiation of murine leukemia-initiating cells via the PTEN\/AKT\/RCOR2\/RUNX1 pathways","volume":"31","author":"Xia","year":"2017","journal-title":"Leukemia"},{"key":"2025111301350915000_13.10.e012314.18","doi-asserted-by":"publisher","DOI":"10.1172\/JCI131375"},{"key":"2025111301350915000_13.10.e012314.19","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1002\/hep.24507","article-title":"Genes inducing iPS phenotype play a role in hepatocyte survival and proliferation in vitro and liver regeneration in vivo","volume":"54","author":"Bhave","year":"2011","journal-title":"Hepatology"},{"key":"2025111301350915000_13.10.e012314.20","unstructured":"Zhu G , Liu W , Shi Y , et al . Single cell rna-seq of cancer-associated fibroblasts in hbv-related hepatocellular carcinoma. 2023 Available: https:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE202642"},{"key":"2025111301350915000_13.10.e012314.21","unstructured":"ENCODE Database . ENCODE project consortium. tf chip-seq in hepg2. 2016. Available: https:\/\/www.encodeproject.org\/experiments\/ENCSR455DOO"},{"key":"2025111301350915000_13.10.e012314.22","unstructured":"ENCODE project consortium . Control chip-seq in hepg2. ENCODE Database; 2016. Available: https:\/\/www.encodeproject.org\/experiments\/ENCSR239QGH"},{"key":"2025111301350915000_13.10.e012314.23","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-022-01328-6"},{"key":"2025111301350915000_13.10.e012314.24","doi-asserted-by":"publisher","DOI":"10.1042\/BCJ20170983"},{"key":"2025111301350915000_13.10.e012314.25","doi-asserted-by":"publisher","DOI":"10.1038\/nsmb.2890"},{"key":"2025111301350915000_13.10.e012314.26","doi-asserted-by":"publisher","DOI":"10.1126\/science.124.3215.267"},{"key":"2025111301350915000_13.10.e012314.27","doi-asserted-by":"crossref","unstructured":"Feng J , Li J , Wu L , et al . Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma. J Exp Clin Cancer Res 2020;39. doi:10.1186\/s13046-020-01629-4","DOI":"10.1186\/s13046-020-01629-4"},{"key":"2025111301350915000_13.10.e012314.28","doi-asserted-by":"crossref","unstructured":"Ganapathy-Kanniappan S , Geschwind J-F . Tumor glycolysis as a target for cancer therapy: progress and prospects. Mol Cancer 2013;12. doi:10.1186\/1476-4598-12-152","DOI":"10.1186\/1476-4598-12-152"},{"key":"2025111301350915000_13.10.e012314.29","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0127-6"},{"key":"2025111301350915000_13.10.e012314.30","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2016.217"},{"key":"2025111301350915000_13.10.e012314.31","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1720948115"},{"key":"2025111301350915000_13.10.e012314.32","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20082173"},{"key":"2025111301350915000_13.10.e012314.33","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-0465"},{"key":"2025111301350915000_13.10.e012314.34","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.171.3.1232"},{"key":"2025111301350915000_13.10.e012314.35","doi-asserted-by":"publisher","DOI":"10.1172\/JCI63428"},{"key":"2025111301350915000_13.10.e012314.36","doi-asserted-by":"crossref","unstructured":"Yu H , Yue X , Zhao Y , et al . LIF negatively regulates tumour-suppressor p53 through Stat3\/ID1\/MDM2 in colorectal cancers. Nat Commun 2014;5. doi:10.1038\/ncomms6218","DOI":"10.1038\/ncomms6218"},{"key":"2025111301350915000_13.10.e012314.37","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41586-019-1130-6","article-title":"Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring","volume":"569","author":"Shi","year":"2019","journal-title":"Nature New Biol"},{"key":"2025111301350915000_13.10.e012314.38","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-21-1888"},{"key":"2025111301350915000_13.10.e012314.39","doi-asserted-by":"crossref","unstructured":"Pascual-Garc\u00eda M , Bonfill-Teixidor E , Planas-Rigol E , et al . LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8+ T cell tumor-infiltration impairing anti-PD1 therapy. Nat Commun 2019;10. doi:10.1038\/s41467-019-10369-9","DOI":"10.1038\/s41467-019-10369-9"},{"key":"2025111301350915000_13.10.e012314.40","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/CCO.0000000000000744","article-title":"The evolving treatment paradigm of advanced hepatocellular carcinoma: putting all the pieces back together","volume":"33","author":"D\u2019Alessio","year":"2021","journal-title":"Curr Opin Oncol"},{"key":"2025111301350915000_13.10.e012314.41","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.01307"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jitc-2025-012314","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T09:35:34Z","timestamp":1763026534000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1136\/jitc-2025-012314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":41,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10,5]]},"published-print":{"date-parts":[[2025,10]]}},"alternative-id":["10.1136\/jitc-2025-012314"],"URL":"https:\/\/doi.org\/10.1136\/jitc-2025-012314","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10]]}}}